CN103028066B - Traditional Chinese medicine composition for treating ankylosing spondylitis - Google Patents

Traditional Chinese medicine composition for treating ankylosing spondylitis Download PDF

Info

Publication number
CN103028066B
CN103028066B CN201210558828.XA CN201210558828A CN103028066B CN 103028066 B CN103028066 B CN 103028066B CN 201210558828 A CN201210558828 A CN 201210558828A CN 103028066 B CN103028066 B CN 103028066B
Authority
CN
China
Prior art keywords
parts
ankylosing spondylitis
traditional chinese
chinese medicine
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210558828.XA
Other languages
Chinese (zh)
Other versions
CN103028066A (en
Inventor
余兰
周瑾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210558828.XA priority Critical patent/CN103028066B/en
Publication of CN103028066A publication Critical patent/CN103028066A/en
Application granted granted Critical
Publication of CN103028066B publication Critical patent/CN103028066B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a traditional Chinese medicine composition for treating ankylosing spondylitis, belonging to the field of traditional Chinese medicines. The traditional Chinese medicine composition for treating the ankylosing spondylitis comprises the following medicinal raw materials in part by weight: 10 parts of mulberry twig, 6 parts of radix aconiti, 8 parts of erycibe obtusifolia, 10 parts of tortoise shell, 8 parts of herba epimedii, 9 parts of achyranthes bidentata, 9 parts of notopterygium root, 12 parts of rhizoma smilacis glabrae, 12 parts of lycopodium clavatum, 8 parts of cistanche deserticola, 9 parts of pyrola, 12 parts of pseudoginseng, 10 parts of cortex lycii radicis, 6 parts of little multibanded krait and 8 parts of processed rehmannia. The traditional Chinese medicine composition uses natural Chinese herbs as the raw materials, is accurate in therapeutic effect and free of toxic side effect, can effectively cure the ankylosing spondylitis with difficulty in relapse, and the effective rate of 96%.

Description

A kind of Chinese medicine composition for the treatment of ankylosing spondylitis
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of ankylosing spondylitis, belong to the field of Chinese medicines.
Background technology
Ankylosing spondylitis (ankylosing spondylitis, AS) is a kind of chronic inflammatory disease, mainly invades sacroiliac joint, spinal column apophysis, the other soft tissue of spinal column and periphery joint, and the extra-articular manifestation that can occur together.Clinical main manifestations is waist, the back of the body, neck, buttocks, hip pain and arthralgia, and deformity of spine and ankylosis can occur severe patient.The common morbidity crowd age, average age of onset was 25 years old between 10~40 years old, and women's sickness rate is low compared with male, and the ratio of men and women's sickness rate is (2-3): 1.
AS insidious onset, patient engenders buttocks hip or low-back pain and/or sends out stiffly, especially, to crouch for a long time (night) or to sit when of a specified duration obviously, stands up difficulty, rises morning or sitting plays immediately waist and sends out obviously stiffly, but alleviates after activity.Some patients feel buttocks hip severe pain, radiate once in a while to periphery.Disease early pain is many is discontinuity in a side, and after the several months, pain is many is persistence at bilateral.With disease progression pathological changes, by sacroiliac joint, to lumbar vertebra, breast cervical vertebra, developed, occur corresponding site pain, limitation of activity or deformity of spine.
At present, AS there is no radical cure method.Patient is by Comprehensive Treatments such as non-medicine, medicine and operations, and alleviating pain and a deadlock, control or reduce inflammation, keep at ordinary times good posture, prevent spinal column or joint deformity, and correction deformity joint if desired, to reach the object of improving patients ' life quality.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition that can effectively treat ankylosing spondylitis, this Chinese medicine preparation can effectively be treated ankylosing spondylitis, determined curative effect and difficult recurrence.
Technical scheme of the present invention is:
Treating a Chinese medicine composition for ankylosing spondylitis, is to be made by the crude drug of following weight parts: Ramulus Mori 10, Radix Aconiti 6, Caulis Erycibes 8, Carapax Et Plastrum Testudinis 10, Herba Epimedii 8, Radix Achyranthis Bidentatae 9, Rhizoma Et Radix Notopterygii 9, Rhizoma Smilacis Glabrae 12, Herba Lycopodii 12, Herba Cistanches 8, Herba Pyrolae 9, Radix Notoginseng 12, Cortex Lycii 10, Bungarus Parvus 6, Radix Rehmanniae Preparata 8.
Single dose dose (unit: gram): Ramulus Mori 10, Radix Aconiti 6, Caulis Erycibes 8, Carapax Et Plastrum Testudinis 10, Herba Epimedii 8, Radix Achyranthis Bidentatae 9, Rhizoma Et Radix Notopterygii 9, Rhizoma Smilacis Glabrae 12, Herba Lycopodii 12, Herba Cistanches 8, Herba Pyrolae 9, Radix Notoginseng 12, Cortex Lycii 10, Bungarus Parvus 6, Radix Rehmanniae Preparata 8.
Preparation and instructions of taking: be decocted in water for oral dose, every day, potion, divided twice one after each meal sooner or later.
The pharmacological action of each Chinese medicine:
Ramulus Mori: micro-hardship, flat.Return Liver Channel.Effect with cure mainly: wind-damp dispelling, sharp joint.Be used for takeing on arm, joint aches numbness.
Radix Aconiti: pungent, bitter, heat; Very toxic.GUIXIN, liver,kidney,spleen warp.Effect with cure mainly: expelling wind and removing dampness, antalgic.For anemofrigid-damp arthralgia, arthralgia, trusted subordinate's cold type of pain, colic of cold type is had a pain, narcotic analgesic.
Caulis Erycibes: pungent, temperature; Slightly poisonous.Return liver, spleen, stomach warp.Effect with cure mainly: expelling wind and removing dampness, reducing swelling and alleviating pain.For rheumatic arthralgia, hemiplegia, tumbling and swelling.
Carapax Et Plastrum Testudinis: salty, sweet, be slightly cold.Return liver, kidney, heart channel.Effect with cure mainly: nourishing YIN for suppressing the hyperactive YANG, kidney tonifying bone strengthening, the reinforcing the heart of nourishing blood.For deficiency of YIN hectic fever, hectic fever due to YIN-deficiency night sweat, has a dizzy spell, stirring-up of pathogenic wind in the interior resulting from deficiency, and muscles and bones flaccidity is soft, has a guilty conscience forgetful.
Herba Epimedii: acrid, sweet, warm.Return liver, kidney channel.Effect with cure mainly: kidney-replenishing, bone and muscle strengthening, wind-damp dispelling.For impotence and seminal emission, muscles and bones flaccidity is soft, rheumatic arthralgia, numbness contracture; Climacteric hypertension.
Radix Achyranthis Bidentatae: bitter, sour, flat.Return liver, kidney channel.Effect with cure mainly: invigorating the liver and kidney, bone and muscle strengthening, eliminating blood stasis and inducing menstruation, conducting blood to flow downwards.For soreness of waist and knee joint, muscles and bones is unable, amenorrhea and mass in the abdomen, dizziness due to hyperactivity of liver-YANG.
Rhizoma Et Radix Notopterygii: pungent, bitter, temperature.Return bladder, kidney channel.Effect with cure mainly: cold expelling, dispel the wind, dehumidifying, pain relieving.For anemofrigid cold headache, rheumatic arthralgia, aching pain in should and back.
Rhizoma Smilacis Glabrae: sweet, light, flat.Return liver, stomach warp.Effect with cure mainly: dehumidifying, removing toxic substances, easing joint movement.For damp and hot stranguria with turbid discharge, leukorrhagia, carbuncle, scrofula disease, scabies, the limbs contracture due to syphilis and mercurialism, bones and muscles pain.
Herba Lycopodii: micro-hardship, pungent, temperature.Return liver,spleen,kidney warp.Effect with cure mainly: expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral.For joint aches, joint stuffiness.
Herba Cistanches: sweet, salty, temperature.Return kidney, large intestine channel.Effect with cure mainly: kidney-replenishing, benefiting essence-blood, loosening bowel to relieve constipation.For sexual impotence, infertile, soreness of the waist and knees, muscles and bones is unable, dryness of the intestine constipation.
Herba Pyrolae: sweet, bitter, temperature.Return liver, kidney channel.Effect with cure mainly: wind-damp dispelling, bone and muscle strengthening, hemostasis.For rheumatic arthralgia, weakness of the waist and knees, menorrhagia, chronic cough due to asthenia of viscera.
Radix Notoginseng: sweet, micro-hardship, temperature.Return liver, stomach warp.Effect with cure mainly: dissipating blood stasis hemostasis, subduing swelling and relieving pain.For spitting of blood, to spit blood, epistaxis, has blood in stool, metrorrhagia, traumatic hemorrhage, breast ventral spine pain, tumbling and swelling.
Cortex Lycii: sweet, cold.Return lung, liver, kidney channel.Effect with cure mainly: removing heat from blood except steam, lung heat clearing pathogenic fire reducing.For deficiency of YIN hectic fever, hectic fever due to YIN-deficiency night sweat, cough due to lung-heat, spitting of blood, epistaxis, interior-heat is quenched one's thirst.
Bungarus Parvus: sweet, salty, temperature; Poisonous.Return Liver Channel.Effect with cure mainly: dispel the wind, dredging collateral, relieving convulsion.For rheumatoid arthritis stubborn, numbness contracture, middle air port is askew, hemiplegia, tic spasm, tetanus, leprosy scabies, scrofula malignant boil.
Radix Rehmanniae Preparata: sweet, tepor.Return liver, kidney channel.Effect with cure mainly: nourishing YIN and supplementing blood, beneficial essence is filled out marrow.For the hepatic and renal YIN deficiency, soreness of the waist and knees, osteopyrexia and fever, night sweat seminal emission, interior-heat is quenched one's thirst, blood deficiency and yellow complexion, severe palpitation, menoxenia, metrostaxis, dizzy, tinnitus, early whitening of beard and hair.
The invention has the beneficial effects as follows: it is raw material that the present invention adopts natural Chinese medicine, determined curative effect and having no side effect, can effectively cure ankylosing spondylitis and be difficult for recurrence, and effective percentage reaches 96%.
Below in conjunction with clinical trial and model case, the present invention is further described.
One, clinical trial
1, clinical data: in 2010, between December to 2011 year December, choose at random patients with ankylosing spondylitis 100 examples of 15~56 years old, be divided at random two groups for the treatment of group and matched groups, wherein, and treatment group 50 examples, male's 32 examples, women's 18 examples, the mean age is 25.4 years old; Matched group 50 examples, male's 34 examples, women's 16 examples, the mean age is 25.8 years old.
2, diagnostic criteria:
(1), symptom: take both sides sacroiliac joint, lower back repeatedly pain as main;
(2), sign.Early, patient's spinal column activity in mid-term is limited in various degree, patients with terminal spinal column occurs that tetanic property is bow-backed fixing, thorax mobility reduces or disappears;
(3), lab testing.Erythrocyte sedimentation rate speeds more, rheumatoid factor negative, the HLA-B27 positive;
(4), x-ray inspection has typical case's change of ankylosing spondylitis and sacroiliitis.Early stage: sacroiliac joint gap is fuzzy, and slightly fine and close, joint space broadening.Mid-term: joint space is narrow, edge, joint hypertrophy with corrode staggered, indentation, the broadening of ilium side seam compact zone, the widelyst reaches 3 centimetres.In late period: joint space disappears, bone compact zone disappears, and bone trabecula passes through, and has been bony ankylosis.
3, Therapeutic Method: treatment group is taken medicine of the present invention, and every day is oral meal at twice; Matched group is taken sulfasalazine and methotrexate, each 0.5g, and every day is oral meal at twice.
4, efficacy assessment standard:
Cure: heavy stiff transference cure, sacroiliac joint and each arthralgia symptom disappear, and arthroncus disappears, and joint motion is freely; Each joint positive sign disappears, and it is normal that each joint physiological function is recovered.
Effective: heavy stiff symptom is clearly better, and sacroiliac joint and each arthralgia symptom are clearly better, and arthroncus is clearly better, and joint motion obviously improves; Each joint positive sign is clearly better, and each function of joint is obviously recovered.
Effective: heavy stiff symptom takes a turn for the better, and sacroiliac joint and each arthralgia symptom take a turn for the better, and arthroncus takes a turn for the better, and joint motion improves; Each joint positive sign alleviates, and each function of joint is improved.
Invalid: heavy stiff symptom is without improvement, and sacroiliac joint and each arthralgia symptom are without improvement, and arthroncus is unchanged; Each joint positive sign is without improvement, and each function of joint is unchanged.
5, therapeutic outcome:
? Cure Effective Effectively Invalid Total effective rate %
Treatment group 29 13 6 2 96%
Matched group 6 10 16 18 64%
The specific embodiment
Embodiment
Proportioning (unit: gram): Ramulus Mori 10, Radix Aconiti 6, Caulis Erycibes 8, Carapax Et Plastrum Testudinis 10, Herba Epimedii 8, Radix Achyranthis Bidentatae 9, Rhizoma Et Radix Notopterygii 9, Rhizoma Smilacis Glabrae 12, Herba Lycopodii 12, Herba Cistanches 8, Herba Pyrolae 9, Radix Notoginseng 12, Cortex Lycii 10, Bungarus Parvus 6, Radix Rehmanniae Preparata 8.
Preparation and instructions of taking: be decocted in water for oral dose, every day, potion, divided twice one after each meal sooner or later.

Claims (1)

1. treat a Chinese medicine composition for ankylosing spondylitis, it is characterized in that being made by the crude drug of following weight parts: Ramulus Mori 10, Radix Aconiti 6, Caulis Erycibes 8, Carapax Et Plastrum Testudinis 10, Herba Epimedii 8, Radix Achyranthis Bidentatae 9, Rhizoma Et Radix Notopterygii 9, Rhizoma Smilacis Glabrae 12, Herba Lycopodii 12, Herba Cistanches 8, Herba Pyrolae 9, Radix Notoginseng 12, Cortex Lycii 10, Bungarus Parvus 6, Radix Rehmanniae Preparata 8.
CN201210558828.XA 2012-12-20 2012-12-20 Traditional Chinese medicine composition for treating ankylosing spondylitis Active CN103028066B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210558828.XA CN103028066B (en) 2012-12-20 2012-12-20 Traditional Chinese medicine composition for treating ankylosing spondylitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210558828.XA CN103028066B (en) 2012-12-20 2012-12-20 Traditional Chinese medicine composition for treating ankylosing spondylitis

Publications (2)

Publication Number Publication Date
CN103028066A CN103028066A (en) 2013-04-10
CN103028066B true CN103028066B (en) 2014-04-23

Family

ID=48015795

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210558828.XA Active CN103028066B (en) 2012-12-20 2012-12-20 Traditional Chinese medicine composition for treating ankylosing spondylitis

Country Status (1)

Country Link
CN (1) CN103028066B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103989854A (en) * 2014-06-02 2014-08-20 孙琳 Traditional Chinese medicine preparation for treating ankylosing spondylitis and preparation method thereof
CN104138436A (en) * 2014-06-27 2014-11-12 桂林浩新科技服务有限公司 Traditional Chinese medicine composition for treating ankylosing spondylitis
CN104225388A (en) * 2014-09-15 2014-12-24 洪立新 Traditional Chinese medicine composition for treating ankylosing spondylitis
CN105832961A (en) * 2016-03-23 2016-08-10 山东青岛中西医结合医院 Traditional Chinese medicine preparation for treating ankylosing spondylitis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1150922C (en) * 2001-02-21 2004-05-26 杨玉明 Medicated wine for treating rheumatism, rheumatoid disease and other arthralgia
CN1236803C (en) * 2002-03-20 2006-01-18 郑国芃 Rheuamtism treating Chinese medicine
CN1466980A (en) * 2002-07-09 2004-01-14 李占云 Medicine-shape medicine for treating rheumatism and bone disease
CN101406646A (en) * 2008-11-26 2009-04-15 路敦祥 Chinese medicinal liquor for treating arthritis
CN102283942A (en) * 2011-09-16 2011-12-21 耿彬 Orally-administrated Chinese medicinal preparation for treating ankylosing spondlitis
CN102784328B (en) * 2012-08-26 2014-06-04 孙超 Medicament for treating ankylosing spondylitis and preparation method of medicament

Also Published As

Publication number Publication date
CN103028066A (en) 2013-04-10

Similar Documents

Publication Publication Date Title
CN102872299B (en) Medicine compound for treating osteoporosis and osteoporosis fracture
CN103550517B (en) A kind of medicine of Hepatoma therapy
CN103028066B (en) Traditional Chinese medicine composition for treating ankylosing spondylitis
CN101628042B (en) White paeony root and pawpaw soup used for lumbar vertebrae hyperosteogeny
CN102935205B (en) Traditional Chinese medicine composition for treating mammary gland hyperplasia
CN104225487A (en) Traditional Chinese medicine for treating lumbar hyperosteogeny
CN103705801A (en) Chinese medicament decoction for treating hyperostosis
CN106362066A (en) Medicinal liquor for treatment of rheumatic and rheumatoid diseases and preparation method thereof
CN102836276B (en) Bone spur softening pill for treating osteoarthritis
CN106692814A (en) Bone disease treatment plaster and making method thereof
CN102218119B (en) Chinese herbal medicine for treating rheumatism, femoral head necrosis and puerperal fever
CN105106854A (en) Traditional Chinese medicine preparation for treating lumbar spondylosis
CN104069447A (en) Traditional Chinese medicine preparation for treating ankylosing spondylitis
CN104398927A (en) Traditional Chinese medicinal preparation for treating gonarthromeningitis
CN104000999A (en) Traditional Chinese medicine composition for treating ischemic necrosis of femoral head
CN103845547A (en) Traditional Chinese medicine decoction for treating mumps
CN104547232A (en) Traditional Chinese medicine for treating ankylosing spondylitis
CN103432311B (en) The Chinese medicine composition of traditional Chinese medicine fumigating moxibustion therapy treatment ankylosing spondylitis
CN105213793A (en) Cure mainly osteoporotic Chinese medicine composition and method for making
CN104208531A (en) Traditional Chinese medicine composition for treating lumbar hyperostosis
CN105012656A (en) Chinese herbal medicine solution capable of curing cervical spondylosis, arthritis and osteoproliferation and preparation method of Chinese herbal medicine solution
CN104352858B (en) A kind of Chinese medicine composition for the treatment of infantile diarrhea
CN104208404A (en) Traditional Chinese medicine composition for treating lumbar disc herniation
CN104383417A (en) Medicine for curing breast cancer
CN104127839A (en) Yin dissipating paste

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant